Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-12-352730
Filing Date
2012-08-13
Accepted
2012-08-13 17:16:23
Documents
13
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT #1 d392303d10ka.htm 10-K/A 1213211
2 CONSENT OF DELOITTE & TOUCHE LLP d392303dex231.htm EX-23.1 1922
3 CONSENT OF ERNST & YOUNG LLP d392303dex232.htm EX-23.2 2315
4 CERTIFICATION OF ROBERT L. KIRKMAN, M.D. d392303dex311.htm EX-31.1 6328
5 CERTIFICATION OF JULIE EASTLAND d392303dex312.htm EX-31.2 6503
6 CERTIFICATION OF ROBERT L. KIRKMAN, M.D. d392303dex321.htm EX-32.1 3902
7 CERTIFICATION OF JULIE EASTLAND d392303dex322.htm EX-32.2 4099
  Complete submission text file 0001193125-12-352730.txt   5727405

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT onty-20111231.xml EX-101.INS 1016384
9 XBRL TAXONOMY EXTENSION SCHEMA onty-20111231.xsd EX-101.SCH 22315
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE onty-20111231_cal.xml EX-101.CAL 34632
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE onty-20111231_def.xml EX-101.DEF 118749
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE onty-20111231_lab.xml EX-101.LAB 151245
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onty-20111231_pre.xml EX-101.PRE 121982
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Oncothyreon Inc. (Filer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 0612
Type: 10-K/A | Act: 34 | File No.: 001-33882 | Film No.: 121028537
SIC: 8731 Services-Commercial Physical & Biological Research